kolaviron has been researched along with D-fructopyranose in 1 studies
| Studies (kolaviron) | Trials (kolaviron) | Recent Studies (post-2010) (kolaviron) | Studies (D-fructopyranose) | Trials (D-fructopyranose) | Recent Studies (post-2010) (D-fructopyranose) |
|---|---|---|---|---|---|
| 103 | 0 | 73 | 18,095 | 1,041 | 5,633 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adoga, JO; Channa, ML; Nadar, A | 1 |
1 other study(ies) available for kolaviron and D-fructopyranose
| Article | Year |
|---|---|
Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Flavonoids; Fructose; Inflammation Mediators; Insulin; Lipids; Male; Myocytes, Cardiac; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Sprague-Dawley; Streptozocin | 2021 |